Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

What Is the Optimal Timing for Intradialytic Resistance Exercise? A Randomized Controlled Trial

NCT05889130 is registered in ClinicalTrials.gov with Muş Alparslan University as lead sponsor.

NCT NCT05889130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05889130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
What Is the Optimal Timing for Intradialytic Resistance Exercise? A Randomized Controlled Trial
Lead sponsor
Muş Alparslan University
Phase
Not applicable
Overall status
Completed
Start date
May 13, 2023
Completion date
December 30, 2023
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis